Literature DB >> 8106567

Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins.

T Kelly1, S C Mueller, Y Yeh, W T Chen.   

Abstract

Chicken embryo fibroblasts (CEF) transformed by Rous sarcoma virus invade the extracellular matrix (ECM) using plasma membrane protrusions, termed invadopodia, that contact and dissolve the matrix. Normal cells neither form invadopodia nor degrade the ECM. Here we show that cells expressing invadopodia degrade and enter into a fibronectin-rich matrix produced by normal fibroblasts. Within 6 h after seeding onto the matrix, the invasive cells create an area devoid of matrix fibrils surrounding the cell body. Proteolysis mediates this matrix clearing because sevenfold more radiolabeled matrix is released into the growth media by the transformed cells relative to the normal cells. In addition to this assembled matrix, transformed cells were grown on thin layers of purified ECM proteins, revealing that invadopodia can degrade fibronectin, collagen type I, collagen type IV, and laminin. A 160 kDa protease that is extracted from transformed cells by Triton X-114 partitions into the detergent phase and is prominent in ventral plasma membranes that contact the ECM suggesting that it is a membrane associated protease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106567     DOI: 10.1002/jcp.1041580212

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

1.  Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study.

Authors:  Paul A Rupp; Richard P Visconti; András Czirók; David A Cheresh; Charles D Little
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

Review 2.  Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling.

Authors:  V Everts; E van der Zee; L Creemers; W Beertsen
Journal:  Histochem J       Date:  1996-04

3.  Modulation of in vivo migratory function of alpha 2 beta 1 integrin in mouse liver.

Authors:  W C Ho; C Heinemann; D Hangan; S Uniyal; V L Morris; B M Chan
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

4.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

Review 5.  The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion.

Authors:  Or-Yam Revach; Benjamin Geiger
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

6.  Evaluation of seprase activity.

Authors:  T Kelly
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

7.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

8.  Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma.

Authors:  Carman Man-Chung Li; Guoan Chen; Talya L Dayton; Caroline Kim-Kiselak; Sebastian Hoersch; Charles A Whittaker; Roderick T Bronson; David G Beer; Monte M Winslow; Tyler Jacks
Journal:  Genes Dev       Date:  2013-07-15       Impact factor: 11.361

9.  Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.

Authors:  T Kelly; Y Yan; R L Osborne; A B Athota; T L Rozypal; J C Colclasure; W S Chu
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

10.  Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.

Authors:  Xiaolin Sun; Chenghai Li; Chunmei Zhuang; William C Gilmore; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.